Jul-Aug 2013;33(4):201-208
Calling it a weight-loss tool confuses cellular protection with fat loss
After analyzing complete trial data from the New England Journal of Medicine and clinical experience managing 340+ patients on GLP-1 and GIP agonists, one pattern emerged: patients who understand the timeline and prepare for peak side effects succeed
N bao gm nhiu loi khc nhau, trong 3 loi ph bin v quan trng nht l Alpha Lipoic Acid (ALA), Eicosapentaenoic (EPA) v Docosahexaenoic (DHA)
Schematic depicting generation of Ttpa -liver specific knockout mice to evaluate depletion of -toc in driving tumour growth in mice
Harlan Krumholz, a cardiologist at Yale School of Medicine in New Haven, Conn., told NBC News.If we really want to make the biggest difference on the health of the nation, we have to make sure that the people who would benefit the most have access to medications that are being shown to be beneficial," he said.More informationHarvard Health has more on GLP-1.SOURCE: NBC News, Oct